Brief: Cyclopharm Receives USFDA Approval For Technegas
02/10/2023 02:01
Oct 2 (Reuters) - Cyclopharm Ltd CYC.AX :
* CYCLOPHARM RECEIVES USFDA APPROVAL FOR TECHNEGAS
Source text for Eikon: ID:nASXbDTy9H
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair